tiprankstipranks

FLCNX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

FLCNX Analyst Rating

Hold
530ConsensusRatings
455 Buy
75 Hold
0 Sell
Based on the consensus analyst ratings on 530 stocks held in FLCNX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FLCNX Analyst Price Target

Average Price Target

$32.94
Based on 530 Wall Street analysts offering 12 month price targets to Fidelity Contrafund K6 holdings in the last 3 months. The average price target is $32.94 with a high forecast of $42.48 and a low forecast of $22.83. The average price target represents a 20.72% change from the last price of $27.29.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"18":"$18","43":"$43","24.25":"$24.3","30.5":"$30.5","36.75":"$36.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":42.476,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$42.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.944,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$32.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.828,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$22.83</span>\n  </div></div>","useHTML":true}}],"tickPositions":[18,24.25,30.5,36.75,43],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,27.193538461538463,28.467076923076924,29.740615384615385,31.014153846153846,32.28769230769231,33.56123076923077,34.83476923076923,36.10830769230769,37.381846153846155,38.65538461538461,39.92892307692308,41.202461538461534,{"y":42.476,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,26.460307692307694,27.000615384615386,27.54092307692308,28.08123076923077,28.621538461538464,29.161846153846156,29.70215384615385,30.24246153846154,30.782769230769233,31.323076923076925,31.863384615384618,32.40369230769231,{"y":32.944,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.92,25.68215384615385,25.444307692307692,25.20646153846154,24.968615384615386,24.730769230769234,24.492923076923077,24.255076923076924,24.01723076923077,23.779384615384615,23.54153846153846,23.30369230769231,23.065846153846152,{"y":22.828,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.24,"date":1682899200000,"info":"<div>Price: <b>$19<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.93,"date":1685577600000,"info":"<div>Price: <b>$20<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.84,"date":1688342400000,"info":"<div>Price: <b>$21<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.67,"date":1690848000000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.59,"date":1693526400000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.89,"date":1696204800000,"info":"<div>Price: <b>$21<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.89,"date":1698796800000,"info":"<div>Price: <b>$21<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.31,"date":1701388800000,"info":"<div>Price: <b>$22<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.85,"date":1704153600000,"info":"<div>Price: <b>$23<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.45,"date":1706745600000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.62,"date":1709251200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.15,"date":1711929600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.92,"date":1714521600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$42.48Average Price Target$32.94Lowest Price Target$22.83
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FLCNX Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Verona Pharma
6 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Structure Therapeutics, Inc. Sponsored ADR
6 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Legend Biotech Corporation
15 Buy
1 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Li Auto, Inc.
11 Buy
1 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Moonlake Immunotherapeutics
10 Buy
2 Hold
0 Sell
Strong Buy

FLCNX Stocks With Highest Downside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
CAVA Group, Inc.
8 Buy
3 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Dell Technologies
11 Buy
1 Hold
1 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Williams-Sonoma
5 Buy
10 Hold
2 Sell
Hold
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Vistra Energy
9 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Mettler-toledo International
1 Buy
3 Hold
1 Sell
Hold

FLCNX Mutual Fund FAQ

What is FLCNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Fidelity Contrafund K6’s 12-month average price target is $32.94.
    What is FLCNX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for FLCNX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is FLCNX a Buy, Sell or Hold?
        Currently, no data Available
        What is Fidelity Contrafund K6’s price target?
        The average price target for Fidelity Contrafund K6 is $32.94. This is based on 530 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
        The highest analyst price target is $42.48 ,the lowest forecast is $22.83. The average price target represents N/A Increase from the current price of N/A.
          What do analysts say about Fidelity Contrafund K6?
          Not enough analysts have published a price target to provide an average price target.
          How can I buy shares of FLCNX?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis